Urticaria: all 239 studies

Page 1 of 3. Open to participants first (26), then studies with results posted, then the rest; newest registration first within each.

• A Study to Assess the Efficacy and Safety of THB335 in Adults With Chronic Spontaneous Urticaria (CSU)Not yet recruitingNCT07766499Phase 2
• A Randomised Controlled Trial of ePROM-Guided Flexible Scheduling in DermatologyNot yet recruitingNCT07481019Not applicable
• A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.RecruitingNCT07219615Phase 2
• A Phase 1 Study of GTX-B001 in Healthy Subjects and Patients With Chronic Inducible UrticariaRecruitingNCT07181369Phase 1
• SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)RecruitingNCT07021495
• Identification of Subpopulations of Patients With Cholinergic Urticaria Based on Infrared Exposure Test Results.Not yet recruitingNCT06948188Not applicable
• A Clinical Study to Assess the Safety and Effectiveness of Utixira Lotion and Utixira Tablet in Healthy Adult Human Subjects With Dry or Sensitive Skin Prone to Mild to Moderate Pruritus and UrticariaNot yet recruitingNCT06924840Not applicable
• Interleukin-2 for Refractory Chronic Spontaneous UrticariaRecruitingNCT06924762Phase 2/3
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HS-10561 Capsule in Healthy Chinese Adults and Patients With Chronic Spontaneous Urticaria.Not yet recruitingNCT06864507Phase 1/2
• Survey on the Characteristics of Traditional Medicine Syndromes in Urticaria Patients At Le Van Thinh HospitalNot yet recruitingNCT06859736
• Phase III Clinical Study of Cetirizine Hydrochloride Injection in Treatment of Acute UrticariaRecruitingNCT06819774Phase 3
• Treatment Options for Chronic UrticariaNot yet recruitingNCT06816784Phase 2
• Use of a Digital Psychotherapeutic App to Reduce Symptom Burden in Dermatology PatientsRecruitingNCT06702293Not applicable
• Trial of JYB1904 in Chronic Spontaneous Urticaria.RecruitingNCT06509334Phase 2
• Different Methods of Tranexamic Acid Application in Controlling Peri Operative Bleeding in Gynecomastia SurgeryNot yet recruitingNCT06509256Early Phase 1
• A Study to Explore the Efficacy and Safety of HWH486 in Adults With Chronic Spontaneous UrticariaRecruitingNCT06295302Phase 2
• Efficacy and Safety of Histamine Human Immunoglobulin in the Treatment of Chronic Spontaneous Urticaria (CSU)Not yet recruitingNCT06250400Phase 4
• Angioedema Biomarker Research StudyRecruitingNCT06210698
• Assessment of Serum Levels of Janus Kinase 1 and 2 in Patients With Cholinergic UrticariaRecruitingNCT06201780Not applicable
• Assessment of Serum Levels of Adenosine Deaminase and Immunoglobulin E in Patients With Chronic Spontaneous UrticariaNot yet recruitingNCT05992987
• Allergy and Immunology Natural History StudyRecruitingNCT05584488
• The Association Between Human Microbiome and Vitamin D in Chronic UrticariaRecruitingNCT05497596Not applicable
• Study on the Influence of Climatic and Environmental Factors on Respiratory Diseases in Sanya, Hainan Province, China.RecruitingNCT05330637
• Global Managed Access Program Cohort for Remibrutinib in Adult Patients With Chronic Spontaneous UrticariaAvailableNCT05170724
• Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of UB-221 in Healthy VolunteersNot yet recruitingNCT04404023Phase 1
• Evaluating the Safety and Tolerability and Determining the PK and PD of Single Dose UB-221 in Chronic Spontaneous UrticariaNot yet recruitingNCT04175704Phase 1
• Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects With Chronic Spontaneous UrticariaTerminatedNCT06077773Phase 2Results posted
• Study Evaluating the Efficacy and Safety of Povorcitinib in Adults With Chronic Spontaneous UrticariaCompletedNCT05936567Phase 2Results posted
• A Study to Assess Subcutaneous Lirentelimab (AK002) in Chronic Spontaneous UrticariaTerminatedNCT05528861Phase 2Results posted
• Safety and Efficacy of Intranasal Epinephrine After Administration of ARS -1 in Subjects With Frequent Urticaria FlaresCompletedNCT05496465Phase 2Results posted
• A Safety and Efficacy Study of Remibrutinib in the Treatment of CSU in Japanese Adults Inadequately Controlled by H1-antihistaminesCompletedNCT05048342Phase 3Results posted
• A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1-antihistaminesCompletedNCT05032157Phase 3Results posted
• A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1 AntihistaminesCompletedNCT05030311Phase 3Results posted
• Study of Efficacy and Safety of Ligelizumab in Adolescents and Adults With Chronic Inducible Urticaria Who Remain Symptomatic Despite Treatment With H1- AntihistaminesTerminatedNCT05024058Phase 3Results posted
• Trial to Assess the Efficacy and Safety of LEO 152020 in Adult Patients With Cholinergic UrticariaCompletedNCT04853992Phase 2Results posted
• Study to Evaluate Tezepelumab in Adults With Chronic Spontaneous UrticariaCompletedNCT04833855Phase 2Results posted
• A Study to Investigate the Use of Benralizumab in Patients With Chronic Spontaneous Urticaria Who Are Symptomatic Despite the Use of Antihistamines (ARROYO)TerminatedNCT04612725Phase 2Results posted
• Study of Efficacy and Safety of Ligelizumab in Chronic Spontaneous Urticaria Patients Who Completed a Previous Study With LigelizumabTerminatedNCT04210843Phase 3Results posted
• A Study of LY3454738 in Adults With Chronic Spontaneous UrticariaTerminatedNCT04159701Phase 2Results posted
• An Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of LOU064 in Subjects With CSUCompletedNCT04109313Phase 2Results posted
• This Was a Dose-finding Study to Evaluate Efficacy and Safety of LOU064 in Patients With CSU Inadequately Controlled by H1-antihistaminesCompletedNCT03926611Phase 2Results posted
• A Safety and Efficacy Study of Ligelizumab in the Treatment of CSU in Japanese Patients Inadequately Controlled With H1- AntihistaminesCompletedNCT03907878Phase 3Results posted
• A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic DiseasesCompletedNCT03858634Phase 2Results posted
• A Study to Evaluate the Long-term Safety and Efficacy of Fenebrutinib in Participants Previously Enrolled in a Fenebrutinib Chronic Spontaneous Urticaria (CSU) StudyTerminatedNCT03693625Phase 2Results posted
• A Safety Study For Prevenar 13 Among Chinese ChildrenCompletedNCT03656939Results posted
• A Phase III Study of Safety and Efficacy of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistaminesCompletedNCT03580369Phase 3Results posted
• A Phase III Study of and Efficacy of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines.CompletedNCT03580356Phase 3Results posted
• A Study to Assess the Efficacy and Safety of AK002 in Subjects With Antihistamine-Resistant Chronic UrticariaCompletedNCT03436797Phase 2Results posted
• Mast Cell Activation Test in Allergic DiseaseCompletedNCT03406325Results posted
• Study of Efficacy and Safety of Xolair® (Omalizumab) in Chinese Patients With Chronic Spontaneous UrticariaCompletedNCT03328897Phase 3Results posted
• A Study of GDC-0853 in Participants With Refractory Chronic Spontaneous Urticaria (CSU).CompletedNCT03137069Phase 2Results posted
• Role of Immunoglobulin E (IgE) Bearing Cells in Chronic Idiopathic Urticaria (CIU)CompletedNCT03111628Phase 4Results posted
• Clinical Trial Comparing JDP-205 to Diphenhydramine Injection for the Treatment of Acute UrticariaCompletedNCT02935699Phase 3Results posted
• A Safety Extension Study to Evaluate the Long-term Safety of QGE031 in Chronic Spontaneous Urticaria (CSU) PatientsCompletedNCT02649218Phase 2Results posted
• Effects of Bilastine on F1 Simulator Driving Performance in Patients Affected by Allergic Rhinitis and/or UrticariaCompletedNCT02576041Phase 4Results posted
• Omalizumab in Chronic Spontaneous Urticaria Patients Non Responding to Initial Standard antihistaminE TreatmentCompletedNCT02550106Phase 4Results posted
• Dose-finding Study of QGE031 as add-on Therapy to Evaluate Efficacy and Safety in Patients With CSUCompletedNCT02477332Phase 2Results posted
• Study to Investigate Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of GSK2646264CompletedNCT02424799Phase 1Results posted
• A Study of the Efficacy and Safety of Omalizumab Through 48 Weeks in Participants With Chronic Idiopathic UrticariaCompletedNCT02392624Phase 4Results posted
• Study of Efficacy and Safety of Omalizumab in Refractory Chronic Spontaneous Urticaria PatientsCompletedNCT02329223Phase 3Results posted
• The Validity, Reliability and Interpretability of Thai-version of Chronic Urticaria Quality of Life QuestionnaireCompletedNCT02285023Results posted
• Omalizumab in Severe and Refractory Solar UrticariaCompletedNCT02262130Phase 2Results posted
• Urticaria Facticia Treatment With Omalizumab (UFO)CompletedNCT02169115Phase 2Results posted
• OPTIMA: Efficacy of Optimized Re-treatment and Step-up Therapy With Omalizumab in Chronic Spontaneous Urticaria (CSU) PatientsCompletedNCT02161562Phase 3Results posted
• Efficacy and Safety of Chemoattractant Receptor-homologous Molecule Expressed on T Helper Type 2 (CRTh2) Antagonist AZD1981 in Chronic Idiopathic Urticaria (CIU) AntihistaminesCompletedNCT02031679Phase 2Results posted
• Pilot Phase III Clinical Trial of JDP-205 IV Injection for Treatment of Acute UrticariaCompletedNCT02023164Phase 3Results posted
• An Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Chronic Urticaria (MK-4117-201)CompletedNCT01916967Phase 3Results posted
• Impact of Omalizumab on Quality of Life Measures and Angioedema Occurrence in Patients With CSU Refractory to TherapyCompletedNCT01723072Phase 3Results posted
• Effect of Omalizumab (Xolair) on Basophils in Patients With Chronic Idiopathic UrticariaCompletedNCT01701583Phase 4Results posted
• Mode of Action Study of Omalizumab in Patients With Chronic Idiopathic Urticaria (CIU) Who Fail to Respond to Antihistamine TreatmentCompletedNCT01599637Phase 2Results posted
• Safety Study of Levocetirizine and FexofenadineCompletedNCT01586091Phase 4Results posted
• Cold Urticaria Treatment With XolairCompletedNCT01580592Phase 2Results posted
• The Role of Vitamin D in Chronic Urticaria and Angioedema TreatmentCompletedNCT01371877Not applicableResults posted
• A Study to Evaluate the Efficacy, Response Duration and Safety of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU)/Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite Antihistamine Treatment (H1)CompletedNCT01292473Phase 3Results posted
• A Study of the Efficacy and Safety of Omalizumab (Xolair) in Patients With Chronic Idiopathic Urticaria (CIU)/Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite Antihistamine (H1) TreatmentCompletedNCT01287117Phase 3Results posted
• Natural History of Chronic UrticariaCompletedNCT01284426Results posted
• A Safety Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic Despite Treatment With H1 Antihistamines, H2 Blockers, and/or Leukotriene Receptor AntagonistsCompletedNCT01264939Phase 3Results posted
• Efficacy and Safety of Miltefosine in Antihistamine Resistant Chronic UrticariaTerminatedNCT01170949Phase 2Results posted
• Safety and Efficacy of Abatacept in Subjects With Chronic Urticaria Who Have Had an Inadequate Response to Anti-histamine TherapyCompletedNCT00886795Phase 1/2Results posted
• A Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic With Antihistamine Treatment (H1)CompletedNCT00866788Phase 2Results posted
• Observation of Side Effects and Effectiveness of Desloratadine (Aerius) Syrup in Filipino Children (Study P05634)CompletedNCT00761527Results posted
• Evaluation of Desloratadine When Used in Patients With Either Allergic Rhinitis or Chronic Idiopathic UrticariaCompletedNCT00724698Results posted
• Safety of Aerius Syrup in Pediatric Patients Aged 1-5 Years Old With Allergic Rhinitis or Chronic Idiopathic Urticaria (Study P04446AM1)(COMPLETED)CompletedNCT00723736Results posted
• Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 MonthsCompletedNCT00628108Phase 3Results posted
• Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 1 to Less Than 6 Years Suffering From Allergic Rhinitis or Chronic Urticaria of Unknown OriginCompletedNCT00619801Phase 3Results posted
• Study for the Treatment of Chronic Idiopathic Urticaria With High Doses of AERIUS (Desloratadine) (Study P04849)CompletedNCT00536380Phase 4Results posted
• Evaluation of the Protection Activity of Microfine Titanium Dioxide (Ti02), Pigmentary Ti02 and Bisoctrizole and Their Combinations in Voluntary Patients With Idiopathic Solar Urticaria (SU)CompletedNCT00483496Phase 2Results posted
• Efficacy and Safety of Omalizumab in Adults (18-70 Years) With Moderate to Severe Chronic UrticariaCompletedNCT00481676Phase 2Results posted
• Rilonacept for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)CompletedNCT00288704Phase 3Results posted
• CUTE (Chronic Urticaria Treatment Evaluation)CompletedNCT00264303Phase 4Results posted
• Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory DiseaseTerminatedNCT00069329Phase 1/2Results posted
• Real-world Evaluation of the Effectiveness of Immunoglobulin-Histamine Complex, IHC (Histoglob) in Chronic UrticariaCompletedNCT07680413
• A Single-Arm Exploratory Study of NatureU Histra Dissolve on Chronic Urticaria SymptomsCompletedNCT07611032Not applicable
• Efficacy and Safety of HA35 Gel for Ultra-Rapid Skin Pruritus ReliefCompletedNCT07580911Not applicable
• Using Artificial Intelligence to Help Doctors Identify Different Skin Conditions and Improve Patient CareCompletedNCT07428954
• Evaluating an Artificial Intelligence Tool to Help Primary Care Doctors Diagnose Skin Conditions.CompletedNCT07428941
• A Phase 1 Study of Cizutamig in IgE Mediated DiseasesWithdrawnNCT07408869Phase 1
• To Compare and Evaluate the Oral Bioavailability of Bilastine 20 mg Orally Dispersible Tablet With That of Bilaxten (Bilastine) 20 mg Orally Dispersible Tablet in Healthy, Adult, Human Subjects Under Fasting ConditionsCompletedNCT07042828Phase 1
• Phase 2b Study of EVO756 in Adults With Moderate to Severe Chronic Spontaneous Urticaria (CSU)CompletedNCT06873516Phase 2
• GI Symptoms in Infants Fed Goat Milk-based Infant FormulaCompletedNCT06755424

← Urticaria overview